Molecule intelOpportunity: ModerateEssentialCrowded market

Timolol

112 brands · 52 companies · product forms

ATC: C07AA06, S01ED01 1 DRAP alert

Opportunity snapshot

Launch attractiveness
37
Market saturation
92
Price room
100
Regulatory risk
50
112
brands
52
companies
Rs 205.2
median price
59
price points
62.98x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 7%

Price room

Across observed sources and strengths
CheapestRs 55.49
MedianRs 205.2
Most expensiveRs 3,495
Spread62.98×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 62.98x across 59 trusted points (Rs 55.49-3495.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Timolol — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2026-04-14
18. Rapid Alert – Spurious TERBIDERM FORTE TABLET (TERBINAFINE 250 mg) & GLANTRIM OPHTHALM

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(8) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

52 canonical companies and 112 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 62.98x across 59 trusted points (Rs 55.49-3495.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-04-14 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.